ZENOVIVE Trademark

Trademark Overview


On Wednesday, December 21, 2011, a trademark application was filed for ZENOVIVE with the United States Patent and Trademark Office. The USPTO has given the ZENOVIVE trademark a serial number of 85500696. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, March 26, 2013. This trademark is owned by Glaxo Group Limited. The ZENOVIVE trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Gene and cell therapy
zenovive

General Information


Serial Number85500696
Word MarkZENOVIVE
Filing DateWednesday, December 21, 2011
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, March 26, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesGene and cell therapy

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 3, 2012
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events


Event DateEvent Description
Tuesday, March 26, 2013ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, March 26, 2013ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, August 28, 2012NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, August 28, 2012INQUIRY TO SUSPENSION E-MAILED
Tuesday, August 28, 2012SUSPENSION INQUIRY WRITTEN
Friday, August 17, 2012ASSIGNED TO LIE
Friday, February 17, 2012NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, February 17, 2012LETTER OF SUSPENSION E-MAILED
Friday, February 17, 2012SUSPENSION LETTER WRITTEN
Tuesday, February 14, 2012ASSIGNED TO EXAMINER
Tuesday, January 3, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, December 24, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords


zenovive therapy cell gene